tiprankstipranks
Biolife Sciences (BLFE)
OTHER OTC:BLFE
US Market

Biolife Sciences (BLFE) Financial Statements

54 Followers

Biolife Sciences Financial Overview

Biolife Sciences's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Biolife Sciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -51.11K$ -82.67K$ -464.21K$ -26.02K$ -28.07K
EBITDA--$ -464.21K$ -26.02K$ -28.07K
Net Income Common Stockholders$ -51.11K$ -82.67K$ -464.21K$ -26.02K$ -28.07K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 828.78K$ 903.91K$ 987.52K$ 2.71K$ 2.98K
Total Assets$ 882.96K$ 923.47K$ 1.00M$ 12.11K$ 11.96K
Total Debt$ 0.00$ 0.00$ 0.00$ 348.85K$ 0.00
Net Debt$ -828.78K$ -903.91K$ -987.52K$ 346.13K$ -2.98K
Total Liabilities$ 396.44K$ 385.85K$ 1.00M$ 12.11K$ 11.96K
Stockholders Equity$ 486.51K$ 537.62K$ 620.30K$ -864.41K$ -838.39K
Cash Flow-
Free Cash Flow$ -389.38K$ -2.71K$ -262.71K$ -261.00$ -35.83K
Operating Cash Flow$ -389.38K$ -2.71K$ -262.71K$ -261.00$ -35.83K
Investing Cash Flow$ -32.06K----
Financing Cash Flow$ 1.25M-$ 1.25M-$ 36.30K
Currency in USD

Biolife Sciences Earnings and Revenue History

Biolife Sciences Debt to Assets

Biolife Sciences Cash Flow

Biolife Sciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis